IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 311 filers reported holding IONIS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.49 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $296 | +41.6% | 6,557 | +27.6% | 0.00% | – |
Q2 2023 | $209 | -5.0% | 5,137 | -17.0% | 0.00% | – |
Q1 2023 | $220 | +58.3% | 6,188 | +66.2% | 0.00% | – |
Q4 2022 | $139 | -99.9% | 3,723 | -8.0% | 0.00% | – |
Q3 2022 | $178,000 | -14.0% | 4,045 | -28.1% | 0.00% | – |
Q2 2022 | $207,000 | +11.3% | 5,625 | +11.2% | 0.00% | – |
Q1 2022 | $186,000 | +5.7% | 5,057 | -13.0% | 0.00% | – |
Q4 2021 | $176,000 | +319.0% | 5,814 | +361.4% | 0.00% | – |
Q3 2021 | $42,000 | -43.2% | 1,260 | -33.4% | 0.00% | – |
Q2 2021 | $74,000 | +7300.0% | 1,891 | +5010.8% | 0.00% | – |
Q1 2021 | $1,000 | -99.1% | 37 | -98.2% | 0.00% | – |
Q4 2020 | $115,000 | +109.1% | 2,046 | +74.3% | 0.00% | – |
Q3 2020 | $55,000 | -42.1% | 1,174 | -27.3% | 0.00% | – |
Q2 2020 | $95,000 | -23.4% | 1,615 | -38.8% | 0.00% | – |
Q1 2020 | $124,000 | -83.7% | 2,639 | -79.0% | 0.00% | -100.0% |
Q4 2019 | $759,000 | -58.6% | 12,570 | -74.9% | 0.00% | -75.0% |
Q3 2016 | $1,832,000 | – | 50,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bellevue Group AG | 9,930,245 | $396,117,000 | 3.87% |
Sicart Associates LLC | 368,409 | $14,696,000 | 3.50% |
Camber Capital Management LP | 2,000,000 | $79,780,000 | 2.69% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 181,781 | $7,251,000 | 1.91% |
SECTOR GAMMA AS | 263,488 | $10,511,000 | 1.86% |
Parkman Healthcare Partners LLC | 136,380 | $5,440,000 | 1.19% |
Eversept Partners, LP | 442,000 | $17,631,380 | 1.18% |
Affinity Asset Advisors, LLC | 75,000 | $2,992,000 | 1.07% |
TANAKA CAPITAL MANAGEMENT INC | 16,661 | $665,000 | 0.90% |
Sonora Investment Management, LLC | 168,665 | $6,728,000 | 0.88% |